Cargando…
ANT‐DBS in epilepsy shows no effect on selected neuropsychiatric tests
OBJECTIVES: Deep brain stimulation of the anterior thalamic nucleus (ANT‐DBS) is an established option in treatment‐resistant epilepsy and obtained FDA approval in 2018. Increased psychiatric comorbidity is well known in epilepsy. The main objective of this study was to investigate possible neuropsy...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545573/ https://www.ncbi.nlm.nih.gov/pubmed/35649713 http://dx.doi.org/10.1111/ane.13658 |